Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New vasopressin V1b receptor antagonists patented by Japanese group

Feb. 24, 2014

Japanese researchers present new agents for neurological disorders and cancer

Feb. 24, 2014

Patient enrollment is ongoing in a phase II study of GSK-249320

Feb. 21, 2014

Purdue Pharma and Shionogi & Co. patent new NOP receptor ligands

Feb. 21, 2014

FDA grants fast track designation to Egalet-001 and Egalet-002

Feb. 21, 2014

TrpV4 inhibition shows promise as a treatment approach for acute ischemic stroke

Feb. 21, 2014

Raptor Pharmaceutical reports results for RP-103 in Huntington's disease

Feb. 21, 2014

Vitae Pharmaceuticals earns milestone payment from Boehringer Ingelheim

Feb. 21, 2014

PAK-01 enhances reperfusion and neuroprotection with no hemorrhagic transformation in vivo

Feb. 20, 2014

Michael J. Fox Foundation awards grant to Ezose Sciences

Feb. 20, 2014

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...